Form 4: AutoZone CEO Philip B. Daniele Reports Stock Option Grants
SEC Form 4 Filing
AutoZone's CEO, Philip B. Daniele, reports the acquisition of non-qualified stock options in a recent SEC Form 4 filing.
Summary
- Philip B. Daniele, President & CEO of AutoZone, Inc., filed a Form 4 with the SEC on October 15, 2024.
- The filing reports the acquisition of non-derivative securities in the form of non-qualified stock options.
- Daniele acquired 4,773 non-qualified stock options with an exercise price of $3,129.78 on October 11, 2024, exercisable starting October 15, 2026, and expiring on October 11, 2034.
- He also acquired 1,555 non-qualified stock options with an exercise price of $3,442.76 on October 11, 2024, exercisable starting October 15, 2029, and expiring on October 11, 2034.
- The options were granted under the AutoZone, Inc. 2020 Omnibus Incentive Award Plan.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests. The sentiment is slightly positive due to the incentive structure.
Positives
- The granting of stock options aligns the CEO's interests with those of the shareholders.
- The vesting schedule encourages long-term performance.
Industry Context
Stock option grants are a common form of executive compensation in the retail and automotive industries, aligning management incentives with shareholder value.
Comparison to Industry Standards
- Companies like O'Reilly Automotive and Advance Auto Parts also utilize stock options as part of their executive compensation packages.
- The vesting schedules and exercise prices are generally benchmarked against industry peers to ensure competitiveness and alignment with performance goals.
Stakeholder Impact
- The stock option grants incentivize the CEO to improve company performance, potentially benefiting shareholders.
- Employees may be indirectly impacted through the CEO's focus on company growth and profitability.
Key Dates
| Date | Description |
|---|---|
| 10/11/2024 | Transaction date for the acquisition of stock options |
| 10/15/2024 | Date of Form 4 filing |
| 10/15/2026 | Date when 50% of the first tranche of options become exercisable |
| 10/15/2029 | Date when the second tranche of options become exercisable |
| 10/11/2034 | Expiration date for both tranches of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.